Found: 11
Select item for more details and to access through your institution.
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00876-w
- By:
- Publication type:
- Article
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 3, p. e225394, doi. 10.1001/jamanetworkopen.2022.5394
- By:
- Publication type:
- Article
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 7, p. 1778, doi. 10.1002/ijc.33447
- By:
- Publication type:
- Article
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.544680
- By:
- Publication type:
- Article
A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. e47, doi. 10.1093/oncolo/oyad224
- By:
- Publication type:
- Article
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. e26, doi. 10.1093/oncolo/oyac190
- By:
- Publication type:
- Article
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. 835, doi. 10.1002/onco.13855
- By:
- Publication type:
- Article
Clinicopathologic and Genomic Characterization of PD‐L1 Positive Urothelial Carcinomas.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. 375, doi. 10.1002/onco.13753
- By:
- Publication type:
- Article
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e153, doi. 10.1002/ONCO.13519
- By:
- Publication type:
- Article
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD‐L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 943, doi. 10.1634/theoncologist.2020-0449
- By:
- Publication type:
- Article